Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 1 - 25 of 1049 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Atenolol	Approved	APOA1	335	decreased	Atenolol results in decreased expression of APOA1 protein	11q23.3	A26374
Atenolol	Approved	APOA2	336	decreased	Atenolol results in decreased expression of APOA2 protein	1q23.3	A26374
Clonidine	Approved	APOA1	335	decreased	Clonidine results in decreased expression of APOA1 protein	11q23.3	A26374
Clonidine	Approved	APOA2	336	decreased	Clonidine results in decreased expression of APOA2 protein	1q23.3	A26374
Atenolol	Approved	APOB	338	increased	Atenolol results in increased expression of APOB protein	2p24.1	A26374
Ethinylestradiol	Approved	THBD	7056	decreased	Ethinyl Estradiol results in decreased expression of THBD protein	20p11.21	A26375
Ethinylestradiol	Approved	F2	2147	increased	Ethinyl Estradiol results in increased expression of F2 protein	11p11.2	A26375
Ethinylestradiol	Approved	F7	2155	increased	Ethinyl Estradiol results in increased expression of F7 protein	13q34	A26375
Losartan	Approved	REN	5972	increased	[Losartan results in decreased activity of AGTR1 protein] which results in increased expression of REN protein	1q32.1	A26376
Alprostadil	Approved Investigational	REN	5972	increased	Alprostadil results in increased expression of REN protein	1q32.1	A26377
Cyproterone acetate	Approved Investigational	KLK2	3817	decreased	Cyproterone Acetate results in decreased expression of KLK2 protein	19q13.33	A26378
Cyproterone acetate	Approved Investigational	KLK3	354	decreased	Cyproterone Acetate results in decreased expression of KLK3 protein	19q13.33	A26378
Estradiol	Approved Investigational Vet Approved	FSHB	2488	decreased	estradiol valerate results in decreased expression of FSHB protein	11p14.1	A26379
Estradiol	Approved Investigational Vet Approved	IGF1	3479	decreased	estradiol valerate results in decreased expression of IGF1 protein	12q23.2	A26379
Estradiol	Approved Investigational Vet Approved	IGFALS	3483	decreased	estradiol valerate results in decreased expression of IGFALS protein	16p13.3	A26379
Estradiol	Approved Investigational Vet Approved	IGFBP3	3486	decreased	estradiol valerate results in decreased expression of IGFBP3 protein	7p12.3	A26379
Estradiol	Approved Investigational Vet Approved	LHB	3972	decreased	estradiol valerate results in decreased expression of LHB protein	19q13.3	A26379
Ethinylestradiol	Approved	IGFALS	3483	decreased	Ethinyl Estradiol results in decreased expression of IGFALS protein	16p13.3	A26379
Ethinylestradiol	Approved	IGFBP3	3486	decreased	Ethinyl Estradiol results in decreased expression of IGFBP3 protein	7p12.3	A26379
Estradiol	Approved Investigational Vet Approved	GH1	2688	increased	estradiol valerate results in increased expression of GH1 protein	17q23.3	A26379
Ethinylestradiol	Approved	GH1	2688	increased	Ethinyl Estradiol results in increased expression of GH1 protein	17q23.3	A26379
Nitroglycerin	Approved Investigational	TNF	7124	decreased	Nitroglycerin results in decreased expression of TNF protein	6p21.33	A26380
Nitroglycerin	Approved Investigational	C3	718	increased	Nitroglycerin results in increased expression of C3 protein alternative form	19p13.3	A26380
Nitroglycerin	Approved Investigational	CXCL8	3576	increased	Nitroglycerin results in increased expression of CXCL8 protein	4q13.3	A26380
Nitroglycerin	Approved Investigational	ELANE	1991	increased	Nitroglycerin results in increased expression of ELANE protein	19p13.3	A26380

Displaying entries 1 - 25 of 1049 in total

Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability